IRIS
MONFORTE, Anna Maria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.196
EU - Europa 7.631
AS - Asia 4.177
SA - Sud America 1.306
Continente sconosciuto - Info sul continente non disponibili 145
AF - Africa 112
OC - Oceania 2
Totale 25.569
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.013
RU - Federazione Russa 3.855
SG - Singapore 1.617
CN - Cina 1.127
BR - Brasile 1.122
IE - Irlanda 888
SE - Svezia 732
VN - Vietnam 678
UA - Ucraina 579
DE - Germania 398
HK - Hong Kong 380
IT - Italia 335
FR - Francia 224
GB - Regno Unito 211
FI - Finlandia 197
IN - India 85
CA - Canada 83
AR - Argentina 69
MX - Messico 51
TR - Turchia 39
AT - Austria 38
BD - Bangladesh 37
EC - Ecuador 36
PL - Polonia 34
IQ - Iraq 32
ZA - Sudafrica 31
CZ - Repubblica Ceca 27
JP - Giappone 24
MA - Marocco 22
NL - Olanda 22
BE - Belgio 21
CO - Colombia 20
UZ - Uzbekistan 19
ES - Italia 18
CI - Costa d'Avorio 15
PK - Pakistan 15
ID - Indonesia 13
SA - Arabia Saudita 13
VE - Venezuela 13
IR - Iran 12
PY - Paraguay 11
CL - Cile 10
CR - Costa Rica 10
BO - Bolivia 9
NP - Nepal 9
TN - Tunisia 9
AE - Emirati Arabi Uniti 8
IL - Israele 8
EG - Egitto 7
KE - Kenya 7
KG - Kirghizistan 7
PE - Perù 7
RO - Romania 7
UY - Uruguay 7
GE - Georgia 6
JM - Giamaica 6
JO - Giordania 6
MY - Malesia 6
SV - El Salvador 6
GR - Grecia 5
HN - Honduras 5
SN - Senegal 5
TT - Trinidad e Tobago 5
AO - Angola 4
AZ - Azerbaigian 4
CH - Svizzera 4
EE - Estonia 4
GT - Guatemala 4
LB - Libano 4
LT - Lituania 4
LV - Lettonia 4
OM - Oman 4
PS - Palestinian Territory 4
PT - Portogallo 4
AL - Albania 3
BA - Bosnia-Erzegovina 3
DO - Repubblica Dominicana 3
EU - Europa 3
KR - Corea 3
KW - Kuwait 3
NI - Nicaragua 3
PA - Panama 3
AU - Australia 2
BG - Bulgaria 2
BY - Bielorussia 2
CW - ???statistics.table.value.countryCode.CW??? 2
CY - Cipro 2
DZ - Algeria 2
GA - Gabon 2
HU - Ungheria 2
LU - Lussemburgo 2
NO - Norvegia 2
PH - Filippine 2
PR - Porto Rico 2
QA - Qatar 2
SR - Suriname 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
Totale 25.413
Salva come PNG Salva come JPEG
Città #
Dallas 4.956
Moscow 1.147
Jacksonville 1.081
Dublin 888
Singapore 854
Ashburn 821
Chandler 745
Dong Ket 507
Nyköping 482
Beijing 401
San Jose 401
Hong Kong 380
Council Bluffs 315
Los Angeles 182
Princeton 179
Cambridge 170
Medford 167
The Dalles 165
Dearborn 149
Lauterbourg 145
Des Moines 134
Boardman 115
Ann Arbor 86
Buffalo 82
New York 78
São Paulo 70
Wilmington 64
Ho Chi Minh City 59
Tianjin 54
Lancaster 49
Guangzhou 46
Milan 43
Belo Horizonte 41
Hanoi 40
Nanjing 40
Jinan 39
Messina 39
Woodbridge 39
Brooklyn 38
San Mateo 38
Munich 37
Columbus 36
Orem 35
Vienna 35
Santa Clara 34
Shenyang 32
Houston 31
Redondo Beach 29
Warsaw 28
Brno 26
Montreal 26
Phoenix 26
Rio de Janeiro 26
Brasília 23
Chicago 23
Haikou 22
Tokyo 22
Hebei 21
Stockholm 21
Denver 20
San Francisco 20
Brussels 19
Chennai 19
Ningbo 19
Pune 18
Shanghai 18
Tashkent 18
Frankfurt am Main 17
London 17
Zhengzhou 17
Amsterdam 16
Campinas 16
Rome 16
Abidjan 15
Atlanta 15
Nuremberg 15
Shenzhen 15
Johannesburg 14
Norwalk 14
Ottawa 14
Porto Alegre 14
Baghdad 13
Helsinki 13
Mumbai 13
Quito 13
Turku 13
Augusta 12
Boston 12
Catania 12
Changsha 12
Guayaquil 12
Manchester 12
Poplar 12
Seattle 12
Taiyuan 12
Hangzhou 11
Mercer Island 11
San José 11
Toronto 11
Ardabil 10
Totale 16.455
Salva come PNG Salva come JPEG
Nome #
1,3-diidro-benzimidazoloni analoghi: progettazione, sintesi e SAR di nuovi inibitori non-nucleosidici dell'RT 4.625
1-[3,5-bis(trifluoromethyl)phenyl]-1H,3H-thiazolo[3,4- a]benzimidazole 323
1-Phenyl-substituted 1H,3H-thiazolo[3,4-a]benzimidazoles and pharmaceutical compositions containing them 304
1-Aryl-1H,3H-thiazolo[3,4-a]benzimidazole derivatives 300
1,3-THIAZOLIDIN-4-ONES:POTENT AND HIGHLY SELECTIVE ANTI-HIV-1 AGENTS 291
1,3-Thiazolidin-4-ones: potent and selective anti-HIV-1 agents 284
1-fluoromethyl-1-methyl-1H,3H-thiazolo-[3,4-a]benzimidazole 279
1-Adamantanamine derivatives as potential anti-HIV agents 262
1H,3H-Thiazolo[3,4-a]benzimidazoles and pharmaceutical compositions containing them 259
2-(2,6-dihalophenyl)-3-(pyrimidin-2-yl)-1,3-thiazolidin-4-ones as non-nucleoside HIV-1 reverse transcriptase inhibitors 213
3-[2-(1H-1,3-benzodiazol-2-yl)ethyl]1,3-oxazolidin-2-one 205
3H-AZIRINO[1,2-D][1,4]BENZODIAZEPIN-4 (5H)-ONES - SYNTHESIS AND STEREOCHEMISTRY 199
A structure-based approach to ligand discovery for inhibition of HIV-1 IN-LEDGF/p75 interaction: a new target for anti-AIDS therapy 193
InVivo Evaluation of Selective Carbonic Anhydrase Inhibitors as Potential Anticonvulsant Agents 193
3H-Azirino[1,2-d][1,4]benzodiazepin-4(5H)-ones: synthesis and stereochemistry 190
Discovery of benzimidazole-based Leishmania mexicana cysteine protease CPB2.8ΔCTE inhibitors as potential therapeutics for leishmaniasis 189
Anti-HIV agents: design and discovery of new potent RT inhibitors 185
Comparative molecular field analysis (CoMFA) and docking studies of non-nucleoside HIV-1 RT inhibitors (NNIs) 179
Microwave-assisted synthesis of benzimidazole and thiazolidinone derivatives as HIV-1 RT inhibitors 172
13C NMR study of tetrahydrothiazolo[3,2-d][1,4]benzodiazepin-3(2H)-ones. 172
Antiretroviral strategy using multi-target agents 172
Sintesi ed attività anti-HIV di 1H,3H-tiazolo[3,4-a]benzimidazoli-sostituiti 171
Graphene Quantum Dots Based Systems As HIV Inhibitors 170
Synthesis and anti-HIV activity of carboxylated and drug-conjugated multi-walled carbon nanotubes 167
Compounds with potential anti-tumor activity VII. Synthesis and anti-tumor activity of 1-aryl-N,N'-di(1,3,4-thiadiazol-2-yl)methylenediamines 161
Computational strategies in discovering novel non-nucleoside inhibitors of HIV-1 RT 161
Modificazioni strutturali del gruppo dichetoacido (DKA) di potenti inibitori dell'Integrasi dell'HIV-1 161
Design, synthesis, structure-activity relationships, and molecular modeling studies of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV agents 160
Antiretroviral strategy: design and synthesis of HIV-1 IN-LEDGF/p75 interaction inhibitors 159
ANNELATED 1,5-BENZODIAZEPINES .1. 3-MEMBERED, 4-MEMBERED, AND 5-MEMBERED RINGS. 157
ANNELATED 1,5-BENZODIAZEPINES .2. 6 MEMBERED RINGS 156
Small Molecules Targeting Protein–Protein Interactions: A Promising Anti-HIV Strategy 156
Annelated 1,5-benzothiazepines 156
Design and synthesis of 2,3-diaryl-1,3-thiazolidin-4one potent HIV-1 RT-inhibitors. 153
ANTICONVULSANT ACTIVITY OF PYRROLO[1',2'-1,2]IMIDAZO[4,5- B]PYRIDINES, PYRROLO[2',1'-2,3]IMIDAZO[4,5-C] PYRIDINES AND PYRROLO[2,1-F]PURINES IN DBA/2 MICE 152
Design, Synthesis and SAR of New Potent HIV-1 RT Inhibitors”. Antiviral Research 151
Discovery of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti- HIV-1 agents 150
Synthesis and metabolic study of 1H,3H-oxazolo[3,4-a]benzimidazoles, a new class of non-nucleoside HIV-1 RT-inhibitors. 146
Design e Sintesi di composti a struttura 3-Indol-Gliossilamidica come potenziali inibitori dell'integrasi dell'HIV-1. 146
COMPUTATIONAL APPROACHES IN DISCOVERING NOVEL ANTI-AIDS AGENTS 143
Synthesis and anti-HIV activity of 2,3-diaryl-1,3-thiazolidin- 4-(thi)one derivatives 143
Synthesis and anti-HIV activity of 2,3-diaryl-1,3-thiazolidin-4-ones 143
Computational and synthetic approaches for the discovery of HIV-1 integrase inhibitors 143
Discovery of HIV-1 Integrase and cellular cofactor LEDGF/p75 interaction inhibitors 143
Derivati benzimidazolonici ed analoghi come potenti inibitori non-nucleosidici dell'RT dell'HIV-1 143
Ciclofunzionalizzazione di 1,4- e 1,5-benzodiazepine: sintesi e stereochimica di nuovi sistemi eteropoliciclici ottenuti per reazione con acidi mercaptoacetici 142
Synthesis and SAR of new 1,3-dihydro-benzimidazolone analogues as non-nucleoside reverse transcriptase inhibitors (NNRTIs) 142
Slow binding-tight binding interaction between benzimidazol-2-one inhibitors and HIV-1 reverse transcriptase containing the lysine 103 to asparagine mutation 142
NOVEL N1-ARYL-2- ARYLTHIOACETAMIDOBENZIMIDAZOLES WERE EFFECTIVE AGAINST HERPES SIMPLEX VIRUS 1 (HSV-1) REPLICATION IN VITRO 142
Structural optimization of N1-aryl-benzimidazoles for the discovery of new non-nucleoside reverse transcriptase inhibitors active against wild-type and mutant HIV-1 strains 141
Searching for novel N1-substituted benzimidazol-2-ones as non-nucleoside HIV-1 RT inhibitors 141
Anti-HIV agents .4. Synthesis and in vitro anti-HIV activity of novel 1-(2,6-difluorophenyl)-1H,3H-thiazolo[3,4- a]benzimidazoles 139
Novel targets for HIV therapy: small molecules blocking IN-LEDGF/p75 interaction 138
Synthesis and structural features of new cyclofunctionalized benzimidazoles 137
Progettazione, Sintesi e SAR di analoghi 1,3-diidro-benzimidazoloni come nuovi agenti anti-HIV 137
Pharmacophore-Based Design of HIV-1 Integrase Strand-Transfer Inhibitors 136
Anti-HIV agents. V. Synthesis, structure and in vitro anti-HIV activity of novel 1H,3H-naphtho[2 ',3 ': 4,5]imidazo[1,2- c]thiazoles 136
Computational and synthetic approaches for the discovery of HIV-1 integrase inhibitors 135
Simulated human digestion of N1-aryl-2-arylthioacetamidobenzimidazoles and their activity against Herpes-simplex virus 1 in vitro 132
A thiazepino[4,5-a]benzimidazole derivative hampers the RNA replication of Eurasian serotypes of foot-and-mouth disease virus 132
Design, synthesis and structure-activity relationships of 1,3-dihydrobenzimidazol-2-one analogues as anti-HIV agents 131
Anti-HIV agents II. Synthesis and in vitro anti-HIV activity of novel 1H,3H-thiazolo[3,4-a]benzimidazoles. 131
Synthesis of new 2,3-diaryl-1,3-thiazolidin-4-ones as anti-HIV agents 129
ANTI-HIV AGENTS .3. SYNTHESIS AND IN-VITRO ANTI-HIV ACTIVITY OF NOVEL 1H,3H-THIAZOLO[3,4-A]IMIDAZO[4,5-B]PYRIDINES 127
Synthesis and antitumour activity of 1H,3H-thiazolo[3,4- a]benzimidazole derivatives 124
Synthesis and anti-HIV activity of 1-(2,6-difluorophenyl)- 1H,3H-thiazolo[3,4-a]benzimidazole structurally-related 1,2- substituted benzimidazoles 124
Sintesi ed attività anti-HIV di 1H,3H-tiazolo[3,4-a]benzimidazoli 1-sostituiti 123
Anti-enterovirus activity and structure-activity relationship of a series of 2,6-dihalophenyl-substituted 1H,3H-thiazolo[3,4-a]benzimidazoles 122
Progettazione razionale e "green" sintesi di nuovi inibitori dell'integrasi dell'HIV-1 119
Compounds with potential antitumor activity. Note VIII 1-Alkyl-N,N'-di(1,3,4-thiadiazol-2-yl)methylenediamines. 119
Synthesis and biological activity of novel 1H,3H-thiazolo[3,4- a] benzimidazoles: non-nucleoside human immunodeficiency virus type 1 reverse transcriptase inhibitors 118
NOVEL PYRROLO- AND THIAZOLO-IMIDAZOLES 118
Computational Strategies for Discovering novel HIV-1 RT Inhibitors 117
Sintesi e valutazione biologica di (ti)azepinobenzimidazoli come potenziali agenti anti-FMDV 116
C-13 NMR-study of tetrahydrothiazolo-[2,3-D][1,4]benzodiazepin-3(2H)-ones 116
ANTI-HIV AGENTS .1. SYNTHESIS AND INVITRO ANTI-HIV EVALUATION OF NOVEL 1H,3H-THIAZOLO[3,4-A]BENZIMIDAZOLES 115
Sintesi e proprietà anticonvulsivanti di 3-(1,3,4-tiadiazol-2-il)tiazolidin-4-oni. 114
MOLECULAR MODELING STUDIES AND SYNTHESIS FOR THE DISCOVERY OF HIV-1 IN-LEDGF/P75 INTERACTION INHIBITORS 112
HIV-1 integrase strand transfer inhibitors (INSTIs): design, synthesis and biological activity 112
HIV-1 RT inhibitors containing a cyclofunctionalized benzimidazole system 111
Rational design, synthesis and SAR of 1,3-dihydro-benzimidazolone analogues as new anti-HIV agents 111
Synthesis, biological activity, pharmacokinetic properties and molecular modelling studies of novel 1H,3H-oxazolo[3,4-a]benzimidazoles: non-nucleoside HIV-1 reverse transcriptase inhibitor 110
Synthesis and in vitro antitumour activity evaluation of 1-aryl-1H,3H-thiazolo[4,3-b]-quinazolines 108
Synthesis and anti-HIV activity of TBZ structurally-related 1,2-substituted benzimidazoles 108
Drug design and synthetic approach for the discovery of novel HIV-1 integrase inhibitors 107
Ligand-based drug design and docking studies of HIV-1 non-nucleoside RT inhibitors 107
DISCOVERY OF 2,3-DIARYL-1,3-THIAZOLIDIN-4-ONES AS POTENT HIV-1 NNRTIS BY MOLECULAR MODELING STUDIES 105
Anti-HIV agents: design and discovery of new potent RT inhibitors 103
Compounds with potential antitumor activity. VI - 2-Alkyl-3-[2-(1,3,4-thiadiazolyl)]-4-thiazolidinones. 103
Pharmacophore Modeling, Docking Experiments And Discovery Of New Hiv-1 NNRTIs 103
Structural features and anti-human immunodeficiency virus (HIV) activity of the isomers of 1-(2',6'-difluorophenyl)-1H,3H- thiazolo[3,4-a]benzimidazole, a potent non-nucleoside HIV-1 reverse transcriptase inhibitor 103
HIV-1 Integrase Inhibitors: Pharmacophore Modeling and Rational Drug Design 102
HIV-1 RT inhibitors containing a cyclofunctionalized benzimidazole system 102
Synthesis and anti-HIV activity of TBZ structurally-related 1,2-substituted benzimidazoles 102
Molecular Modeling Studies: Discovery of Novel Potent Non-Nucleoside RT Inhibitors 101
Synthesis and biological activity of novel non-nucleoside HIV-1 RT inhibitors 101
SYNTHESIS AND ANTIHYPERTENSIVE ACTIVITY EVALUATION OF INDOLE- DERIVATIVES N-ACETAMIDO SUBSTITUTED 101
Molecular Modeling Studies: Discovery of Novel Potent Non-Nucleoside RT Inhibitors 100
ENANTIOMERIC RESOLUTION: HPLC ON CHIRAL STATIONARY PHASE OF ANTI-HIV AGENTS. 100
Discovery of 2,3-diaryl-1,3-thiazolidin-4-ones as potent HIV-1 NNRTIs by molecular modeling studies 99
Totale 19.426
Salva come PNG Salva come JPEG
Categoria #
all - tutte 75.233
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.233
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022788 0 0 0 32 78 8 69 40 28 10 155 368
2022/20232.881 237 216 122 228 255 300 80 180 1.124 12 93 34
2023/2024545 58 101 41 93 52 84 1 23 2 29 12 49
2024/20252.858 54 35 73 212 114 100 31 666 760 116 230 467
2025/202612.756 317 1.805 3.657 699 661 2.055 1.035 1.037 1.020 293 104 73
2026/20271.296 130 303 371 492 0 0 0 0 0 0 0 0
Totale 25.569